66.82MMarket Cap-172P/E (TTM)
0.354High0.321Low1.64MVolume0.330Open0.320Pre Close556.97KTurnover0.96%Turnover RatioLossP/E (Static)207.51MShares1.67052wk High1.18P/B55.04MFloat Cap0.29152wk Low--Dividend TTM170.94MShs Float51.375Historical High--Div YieldTTM10.40%Amplitude0.291Historical Low0.338Avg Price1Lot Size
Sangamo Therapeutics Stock Forum
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet